Detalles de la búsqueda
1.
Occurrence and outcome of de novo metastatic breast cancer by subtype in a large, diverse population.
Cancer Causes Control
; 27(9): 1127-38, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27496200
2.
Estimated Life-Years Saved in Women with HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States.
Value Health
; 18(6): 876-83, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26409616
3.
The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer.
Value Health
; 18(4): 541-6, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26091608
4.
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer.
Cancer
; 120(17): 2657-64, 2014 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24930388
5.
Investigation of adverse-event-related costs for patients with metastatic breast cancer in a real-world setting.
Oncologist
; 19(9): 901-8, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25085897
6.
Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status.
Cancer
; 119(17): 3113-22, 2013 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23775560
7.
Infused therapy and survival in older patients diagnosed with metastatic breast cancer who received trastuzumab.
Cancer Invest
; 29(9): 573-84, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21929325
8.
Symptom burden and quality of life among women with HER2(+) metastatic breast cancer.
Breast J
; 21(2): 208-10, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25655357
9.
Effectiveness of superselective chemoembolization and radiofrequency ablation of hepatocellular carcinoma assessed in 21 explanted livers.
J La State Med Soc
; 160(5): 258-62, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19048980
10.
Aminocaproic-acid seal to reduce or prevent bleeding after liver biopsy.
J La State Med Soc
; 159(1): 46-9, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17396476
11.
Identification of proteases employed by dendritic cells in the processing of protein purified derivative (PPD).
J Immune Based Ther Vaccines
; 2(1): 8, 2004 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-15287985
12.
Comparison of treatment patterns and economic outcomes in metastatic breast cancer patients initiated on trastuzumab versus lapatinib: a retrospective analysis.
Springerplus
; 3: 236, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24936383
13.
Health care utilization and costs by site of service for nonmetastatic breast cancer patients treated with trastuzumab.
J Manag Care Spec Pharm
; 20(5): 485-93, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24761820
14.
Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens.
Springerplus
; 3: 259, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24926422
15.
Bevacizumab confers additional advantage to the combination of trastuzumab plus pertuzumab in trastuzumabrefractory breast cancer model.
Cancer Chemother Pharmacol
; 72(4): 733-45, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23959459
16.
Effect of central nervous system metastases on treatment discontinuation and survival in older women receiving trastuzumab for metastatic breast cancer.
J Cancer Epidemiol
; 2012: 819210, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22570657
17.
Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER.
Clin Cancer Res
; 17(14): 4834-43, 2011 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21768129
18.
In response to L.N. Newcomer et al.
J Oncol Pract
; 11(2): 161, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25515720
19.
Effect of trastuzumab on health-related quality of life in patients with HER2-positive metastatic breast cancer: data from three clinical trials.
Clin Breast Cancer
; 10(4): 288-93, 2010 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20705561
20.
Estimating recurrences prevented from using trastuzumab in HER-2/neu-positive adjuvant breast cancer in the United States.
Cancer
; 116(24): 5575-83, 2010 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20734398
Resultados
1 -
20
de 20
1
Próxima >
>>